Insider filing · MNPR
Chandler Robinson
Chief Executive Officer
profile →
Monopar Therapeutics Inc.
MNPR · Healthcare · 14 filings in 24 months
ticker →
Chandler Robinson sold $2.5M of Monopar Therapeutics (MNPR)
Executed Sep 24, disclosed Sep 29, 4 days later.
Value, as filed
$2.5M
28,456 sh across 3 lots
Executed
Sep 24
the trade date, as filed
Disclosed
Sep 29
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CRChandler Robinson (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $2.5M of MNPR (28,456 sh across 3 lots, as filed), executed Sep 24.
The name
MNPRHealthcare · Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Chandler Robinson in MNPR
MNPRSALE
Monopar Therapeutics Inc.
$672K16,800 sh × $40.00
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET